𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Exemestane in adjuvant treatment of early breast cancer in postmenopausal women: results of a UK cost-effectiveness model

✍ Scribed by K. Wilson; Wordsworth; M. Tabberer; M. Lees; D. Carroll; D. Rea; R. Coleman

Book ID
118624653
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
141 KB
Volume
4
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness of switching to exeme
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to